BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1569811)

  • 1. Prevalence of IgM antibodies to phenolic glycolipid I among household contacts and controls in Korea and the Philippines.
    Cho SN; Kim SH; Cellona RV; Chan GP; Fajardo TT; Walsh GP; Kim JD
    Lepr Rev; 1992 Mar; 63(1):12-20. PubMed ID: 1569811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands.
    Cartel JL; Chanteau S; Boutin JP; Plichart R; Richez P; Roux JF; Grosset JH
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):512-7. PubMed ID: 2205686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae.
    Bührer SS; Smits HL; Gussenhoven GC; van Ingen CW; Klatser PR
    Am J Trop Med Hyg; 1998 Feb; 58(2):133-6. PubMed ID: 9502593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
    Chujor CS; Bernheimer H; Levis WR; Schwerer B
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
    Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia.
    Chanteau S; Glaziou P; Plichart C; Luquiaud P; Plichart R; Faucher JF; Cartel JL
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):533-41. PubMed ID: 8151183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil.
    Frota CC; Freitas MV; Foss NT; Lima LN; Rodrigues LC; Barreto ML; Kerr LR
    Trans R Soc Trop Med Hyg; 2010 Jul; 104(7):490-5. PubMed ID: 20447668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-phenolic glycolipid 1 IgM antibodies in leprosy patients and in their household contacts.
    Sulçebe G; Nakuçi M
    Lepr Rev; 1990 Dec; 61(4):341-6. PubMed ID: 2280655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.
    Düppre NC; Camacho LA; Sales AM; Illarramendi X; Nery JA; Sampaio EP; Sarno EN; Bührer-Sékula S
    PLoS Negl Trop Dis; 2012; 6(6):e1711. PubMed ID: 22724040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of four semi-synthetic Mycobacterium leprae antigens with sera from healthy populations in endemic and non-endemic areas.
    Douglas JT; Steven LM; Hirsch DS; Fujiwara T; Nelson KE; Madarang MG; Cellona RV
    Lepr Rev; 1992 Sep; 63(3):199-210. PubMed ID: 1406016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-PGL-I seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon.
    Barreto JG; Guimarães Lde S; Leão MR; Ferreira DV; Lima RA; Salgado CG
    Lepr Rev; 2011 Dec; 82(4):358-70. PubMed ID: 22439276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
    Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
    Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
    Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
    Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.